Startseite Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis
Artikel Open Access

Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis

  • Xiao Haibing EMAIL logo , Cao Xu , Cai Jifu , Zeng Wenshuang , Li Ling , Cui Yuzhen und Hu Yanjun
Veröffentlicht/Copyright: 22. Juli 2016

Abstract

Objective

The aim of this meta-analysis was to undertake a meta-analysis to evaluate the correlation between cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene rs221775 A>G single nucleotide polymorphism and the susceptibility of multiple sclerosis (MS) susceptibility.

Method

Published manuscripts about CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility were searched in the computerized bibliographic searches of Pubmed Embase and China National Knowledge Infrastructure (CNKI). Potential studies were screened and data for 5025 MS patients and 4706 controls from 20 publications were included. The association between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility were demonstrated by odds ratio (OR) and 95% confidence interval (95%CI).

Results

The pooled results showed no significant association between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility for dominant genetic model [OR=1.02, 95%CI:0.90~1.05, (P=0.80)], homozygous genetic model [OR=0.85,95%CI:0.71 ~1.03,(P=0.10)] and recessive genetic model [OR=0.99,95% CI:0.89~1.10,(P=0.90)].

Conclusion

With current evidence, CTLA-4 gene rs221775A>G single nucleotide polymorphism had no association with the susceptibility of multiple sclerosis

1 Introduction

Multiple sclerosis (MS) is a kind of demyelinating disease in which the insulating cover of nerve cells in the brain and spinal cord are damaged. And it was reported that MS is the most common diagnosized autoimmune disease which can affect the central nervous system. Clinical epidemology study estimated that about 2,300,000 subjects were affected by MS globally in the year of 2013, and about 20,000 people died from MS at the same year [1]. MS has the ability to reduce the communication of the central nervous system, which can lead to a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems [2]. Generally, MS is not believed to be a hereditary disease, but some studies indicated that the genetic variations could have an association with the increasing risk of developing MS [3]. One of the related genes is cytotoxic T lymphocyte-associated antigen 4(CTLA-4), which is expressed on the surface of T cells and is critical in inhibiting T cell activation. Several studies have reported a significant correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility [4, 5]. However, other studies have not find a significant correlation [6-8]. Thus, we performed a meta-analysis by pooling all the available data related to CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility in order to further evaluted the corrlation.

2 Method

2.1 Publication search strategy

The open published studies about the CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility were searched in the databases of Pubmed Embase and China National Knowledge Infrastructure (CNKI). The case-control or cohort studies published in English or Chinese were all searched in the databases before Jan 2016. The search strategy and text words were: “cytotoxic T lymphocyte associated antigen/CTLA-4/CTLA4”, “multiple sclerosis/MS” or “polymorphism”. The references for the included papers were also screened to identify additional potential suitable studies which were not indexed in the pubmed or CNKI databases.

2.2 Inclusion and exclusion criteria

The inclusion criteria were as follows: (1) the study design was cases-cotrol or cohort; (2) the paper was published in English or Chinese; (3) the genotyping method is correct; (4) the frequency of AA, AG and GG nucleotide can be extracted from the original study. And the exclusion criteria were: (1) the study design type were review or case report; (2) studies with duplicate published datas; (3) Studies publised in other languages (not English or Chinese); (4) the data extracted from the original studies was not enough to calculate the ORs.

2.3 Data evaluation

Two reviewers (XIAO Haibing & CAO Xu) of this manuscript independently reviewed the papers and extracted the data according to the Cochrane Handbook. The general information such as first author, the paper publication year, the country of the study performed, and the race of the included subjects for each of the included paper were extacted. The frequency of AA, AG and GG nucleotide for the include 20 studies were canrefully extracted and corss checked, which was used to calculated the pooled ORs. If disagreements were encountered, the discussion was made and a third reviewer was consulted.

2.4 Statistical analysis

Stata/SE 11.0(StataCorp LP, http://www.stata.com were used for statistical analysis. The correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility was demonstrated by odds ratio (OR) and its 95% confidence interval (95%CI). Statistical heterogeneity among studies was evaluated by I2 [9]. If significant heterogeneity was found (I2>50%), the random-effect method (Dersimonian-Laird method) was used to pool the data. Inversely, fixed-effect method was applied. The publication bias was detected by Begg’s funnelplot.

3 Results

3.1 General information of the included studies

Through searching the databases, 86 related publication were initial identified. 66 studies were excluded after reviewing the complete text. Overall, we included twenty published articles in this meta-analysis with 5025 MS patients and 4706 controls. For the inlcuded 20 open published studies, 14 articles included the subjects with race of Caucasus, 3 with Arab, 1 with mixed, 1 with Asian and 1 with Australoid. The publication year ranged form 1999 to 2011. All papers were published in English. General information of the included 20 papers are demonstrated in Table 1.

Table 1

General information for the included studies

AuthorsYearCountryRaceNoCaseControl
MSControlAAAGGGAAAGGG
Ligers etal[4]1999SwedenCaucasus378237117188738312331
Rasmussen(1) et al[6]2001DenmarkCaucasus84125283917356822
Rasmussen(2) et al[6]2001DenmarkCaucasus42864231573445
Andreevskii et al[7]2002RussiaCaucasus1682095185326810437
Masterman et al[8]2002SwedenCaucasus374290120188668213969
Maurer et al[5]2002GermanyCaucasus33015213215741666917
Bocko et al[10]2003PolandCaucasus102101315714355313
Kantarci et al[11]2003USAMixed1202354559158911135
van Veen et al[12]2003NetherlandsCaucasus51418121522970728524
Bilinska et al[13]2004PolandCaucasus152154478025508420
Teutsch et al[14]2004AustraliaCaucasus102152305418646127
Fukazawa et al[15]2005JapanAsian133156236941296661
Lorentzen et al[16]2005NorwayCaucasus5135091642519816824992
Malferrari etal [17]2005ItalyCaucasus9510440469375413
Dincic et al[18]2006MontenegroCaucasus16210296561041529
Heggarty et eal[19]2007EnglandCaucasus33015812914853468428
Greve(1) etal [20]2008PolandCaucasus180171599625499032
Greve(2) etal[20]2008GermanyCaucasus20046475903517821670
Greve(3) etal[20]2008HungaryCaucasus19391649633324811
Wray et al[21]2008AustraliaAustraloid19822465111228610731
Yousefipour et al [1]2009IranArab1531907956181175914
Heidari et al[22]2010IranArab135135426924387423
Cizmarevic et al[23]2011IranArab3674801511655119822161

3.2 Dominant genetic model (GG+AG vs AA)

For the dominant genetic model (GG+AG vs AA), significant heterogeneity across the included twenty article existed (I2=82.5%, P=0.00). The OR was pooled by random effect model. The pooled OR was 1.06 and 95% confidence interval was 0.86~1.30 wich indicated that there was no significant association between CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility in dominant genetic model (GG+AG vs AA (Figure 1). The begg’s funnel plot indicated no significant publication bias (Figure 2).

Figure 1 The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under dominant model (GG+AG vs AA).
Figure 1

The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under dominant model (GG+AG vs AA).

Figure 2 The Begg’s funnel plots showe no significant publication bias under dominant model (GG+AG vs AA)
Figure 2

The Begg’s funnel plots showe no significant publication bias under dominant model (GG+AG vs AA)

3.3 Homozygous genetic model (GG vs AA)

For the homozygous genetic model (GG vs AA), no significant heterogeneity across the included 20 articles were found (I2=0.80%, P=0.45). So, the OR was pooled by fixed effect model. The pooled OR showed no significant correlation between CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility was found in homozygous genetic model (GG vs AA) (Figure 3). The pulication bias was evaluated by funnel plot, which indicated no significant publication bias (Figure 4).

Figure 3 The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under homozygous genetic model (GG vs AA).
Figure 3

The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under homozygous genetic model (GG vs AA).

Figure 4 The Begg’s funnel plots showe no significant publication bias homozygous genetic model (GG vs AA).
Figure 4

The Begg’s funnel plots showe no significant publication bias homozygous genetic model (GG vs AA).

3.4 Recessive genetic model (GG vs AG+AA)

For the recessive genetic model (GG vs AG+AA), the heterogeneity across the studies were assesed by I2 which showed no significant heterogeneity across the studies (I=81.2%, P=0.45). We pooled the data by fixed effect mode. The pooled the results indicated no statistical association between CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility in recessive genetic model (GG vs AG+AA) (Figure 5). And begg’s funnel plot was symmetric which indicated no significant publication bias (Figure 6).

Figure 5 The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under recessive genetic model (GG vs AG+AA)
Figure 5

The forest plot of OR for CTLA-4 gene rs221775 A>G single nucleotide polymorphism and multiple sclerosis susceptibility under recessive genetic model (GG vs AG+AA)

Figure 6 The Begg’s funnel plots showe no significant publication bias under recessive genetic model(GG vs AG+AA)
Figure 6

The Begg’s funnel plots showe no significant publication bias under recessive genetic model(GG vs AG+AA)

4 Discussion

Generally, the causes for MS is unclear. However, it is believed that it could be the result of a combination of genetic and environmental factorial influences (such as infectious agents) [24]. Results of publised studies have demonstrated that some genetic variations can increase the risk of developing MS [11]. These genes seem to be expresed higher in microglial cells than expected by chance. Cytotoxic T-lymphocyte-associated protein 4 gene was one of these genes that was positive expressed in activated T lymph cells and played an important role in inhibiting the function of T lymph cell [25].

CTLA-4, also known as CD152 (cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint, downregulates the immune system. Animal experiment showed that disruption of CTLA-4 leads to fatal lymphoproliferative disorder, which could result in a widespread autoimmunity in mice [26]. Recently, seveal studies have found the cytotoxic T-lymphocyte-associated protein 4(CTLA-4) gene rs221775A>G single nucleotide polymorphism to be associated with the susceptibility of multiple sclerosis [4, 19]. Heggarty and his colleges [19] discussed the relationship between CTLA4 gene polymorphisms and multiple sclerosis risk in Northern Ireland. They found that people with A allele and AA genotype of rs221775 had more risk of developing MS (OR=1.36, P<0.05 for A allele and OR=1.81, P<0.05 for AA genotype).

Significnat correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and MS risk was demonstrated in their study. Kantarci et al [11] also found that CTLA4 was associated with susceptibility to multiple sclerosis. They performed a population-based sample of 122 sporadic patients with MS and 244 age-, gender- and ethnicity-matched controls, and by linkage and family-based association methods in 395 individuals from 59 American multiplex pedigrees with 141 affected individuals. They found a strong association with age at onset, disease course and severity. Moreover they found that CTLA-4 was associated with the susceptibility to MS.

On the other hand, Greve et al [20] found no association between CTLA4 polymorphism and MS susceptibility in patients from Germany, Hungary and Poland. Thus, the results for CTLA4 polymorphism and MS risk is not conclusive within published articles. The current meta-analysis pooling of publised data were preformed in order to further evaluated the correlation between CTLA4 gene polymorphisms and multiple sclerosis. We included 20 studies involving 5025 MS patients and 4706 controls. No significant correlation between CTLA4 polymorphism and MS in dominant genetic model (GG+AG vs AA), homozygous genetic model (GG vs AA) or recessive genetic model(GG vs AG+AA) genetic model were found.

There are several limitations with the present meta-analysis to be considered. Firstly, heterogeneity existed in dominant genetic model (GG+AG vs AA), which could reduce the statistical power for pooling the data. Secondly, only paper published in English or Chinese had been screened in the databases and include. Thirdly, MS is a complex diseases, which is the result of the combined actions of multiple susceptibility genes and one or more environmental factors, and only the association between one single nucleotide polymorphism for one gene was evaluated which may not be enough.

Funding from Shenzhen Science, Technology and Innovation Committee. No. JCYJ20150331142757395

Conflict of interest statement

Authors state no conflict of interest.


Xiao Haibing, Neurology, Internal Medicine, The University of Hong Kong-Shenzhen Hospital. No 1, Haiyuan 1st Road, Futian District, Shenzhen, Guangdong, PR China. 518053

References

[1] Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta Neurol Scand. 2009. 120(6): 424-42910.1111/j.1600-0404.2009.01177.xSuche in Google Scholar

[2] Kampman MT, Eriksen EF, Holmoy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications. Acta Neurol Scand Suppl. 2011. (191): 44-4910.1111/j.1600-0404.2011.01543.xSuche in Google Scholar

[3] MacLean HJ, Freedman MS. Multiple sclerosis: following clues from cause to cure. The Lancet. Neurology. 2009. 8(1): 6-810.1016/S1474-4422(08)70272-2Suche in Google Scholar

[4] Ligers A, Xu C, Saarinen S, Hillert J, Olerup O. The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol. 1999. 97(1-2): 182-19010.1016/S0165-5728(99)00072-7Suche in Google Scholar

[5] Maurer M, Ponath A, Kruse N, Rieckmann P. CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis. J Neuroimmunol. 2002. 131(1-2): 213-21510.1016/S0165-5728(02)00275-8Suche in Google Scholar

[6] Rasmussen HB, Kelly MA, Francis DA, Clausen J. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. J Neurol Sci. 2001. 184(2): 143-14710.1016/S0022-510X(00)00502-5Suche in Google Scholar

[7] Andreevskii TV, Sudomoina MA, Gusev EI, Boiko AN, Alekseenkov AD, Favorova OO. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians]Molekuliarnaia biologiia. 2002. 36(4): 643-8.10.1023/A:1019800410254Suche in Google Scholar

[8] Masterman T, Ligers A, Zhang Z, et al. CTLA4 dimorphisms and the multiple sclerosis phenotype. J Neuroimmunol. 2002. 131(1-2): 208-21210.1016/S0165-5728(02)00274-6Suche in Google Scholar

[9] Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003. 327(7414): 557-56010.1136/bmj.327.7414.557Suche in Google Scholar

[10] Bocko D, Bilinska M, Dobosz T, et al. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch Immunol Ther Exp (Warsz). 2003. 51(3): 201-205Suche in Google Scholar

[11] Kantarci OH, Hebrink DD, Achenbach SJ, et al. CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol. 2003. 134(1-2): 133-14110.1016/S0165-5728(02)00395-8Suche in Google Scholar

[12] van Veen T, Crusius JB, van Winsen L, et al. CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis. J Neuroimmunol. 2003. 140(1-2): 188-19310.1016/S0165-5728(03)00184-XSuche in Google Scholar

[13] Bilinska M, Frydecka I, Noga L, et al. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurol Scand. 2004. 110(1): 67-7110.1111/j.1600-0404.2004.00271.xSuche in Google Scholar PubMed

[14] Teutsch SM, Booth DR, Bennetts BH, Heard RN, Stewart GJ. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. J Neuroimmunol. 2004. 148(1-2): 218-23010.1016/j.jneuroim.2003.12.003Suche in Google Scholar PubMed

[15] Fukazawa T, Kikuchi S, Miyagishi R, et al. CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese. J Neuroimmunol. 2005. 159(1-2): 225-22910.1016/j.jneuroim.2004.10.012Suche in Google Scholar PubMed

[16] Lorentzen AR, Celius EG, Ekstrom PO, et al. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J Neuroimmunol. 2005. 166(1-2): 197-20110.1016/j.jneuroim.2005.06.002Suche in Google Scholar PubMed

[17] Malferrari G, Stella A, Monferini E, et al. Ctla4 and multiple sclerosis in the Italian population. Exp Mol Pathol. 2005. 78(1): 55-5710.1016/j.yexmp.2004.10.001Suche in Google Scholar PubMed

[18] Dincic E, Zivkovic M, Stankovic A, et al. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population. J Neuroimmunol. 2006. 177(1-2): 146-15010.1016/j.jneuroim.2006.05.005Suche in Google Scholar PubMed

[19] Heggarty S, Suppiah V, Silversides J, et al. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. J Neuroimmunol. 2007. 187(1-2): 187-19110.1016/j.jneuroim.2007.04.017Suche in Google Scholar PubMed

[20] Greve B, Simonenko R, Illes Z, et al. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Multiple sclerosis (Houndmills, Basingstoke, England). 2008. 14(2): 153-15810.1177/1352458507082357Suche in Google Scholar PubMed

[21] Wray BN, Stankovich J, Whittock L, et al. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population. J Neuroimmunol. 2008. 196(1-2): 139-14210.1016/j.jneuroim.2008.02.001Suche in Google Scholar PubMed

[22] Heidari A, Noori DMR, Keramatipour M, Rashikinezhad A, Sahmani AA, Amirzargar AA. CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol. 2010. 9(4): 219-223Suche in Google Scholar

[23] Cizmarevic NS, Gasparovic I, Peterlin B, et al. CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Int J Immunogenet. 2011. 38(5): 419-42610.1111/j.1744-313X.2011.01027.xSuche in Google Scholar

[24] Taylor BV. The major cause of multiple sclerosis is environmental: genetics has a minor role--yes. Multiple sclerosis (Houndmills, Basingstoke, England). 2011. 17(10): 1171-117310.1177/1352458511421105Suche in Google Scholar

[25] Alizadeh M, Babron MC, Birebent B, et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann Neurol. 2003. 54(1): 119-12210.1002/ana.10617Suche in Google Scholar

[26] Chambers CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 1997. 7(6): 885-89510.1016/S1074-7613(00)80406-9Suche in Google Scholar

Received: 2016-3-29
Accepted: 2016-6-13
Published Online: 2016-7-22
Published in Print: 2016-1-1

© 2016 Xiao Haibing et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Research Article
  2. The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
  3. Case Report
  4. Urethral stone of unexpected size: case report and short literature review
  5. Case Report
  6. Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
  7. Research Article
  8. FPL tendon thickness, tremor and hand functions in Parkinson’s disease
  9. Research Article
  10. Diagnostic value of circulating tumor cells in cerebrospinal fluid
  11. Research Article
  12. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma
  13. Research Article
  14. MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
  15. Research Article
  16. Association of HOTAIR expression with PI3K/Akt pathway activation in adenocarcinoma of esophagogastric junction
  17. Research Article
  18. The role of interleukin genes in the course of depression
  19. Case Report
  20. A rare case of primary pulmonary diffuse large B cell lymphoma with CD5 positive expression
  21. Research Article
  22. DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis
  23. Research Article
  24. The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
  25. Case Report
  26. Dysphonia – the single symptom of rifampicin resistant laryngeal tuberculosis
  27. Review Article
  28. Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
  29. Research Article
  30. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
  31. Research Article
  32. Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
  33. Research Article
  34. Blood cells in thyroid cancer patients: a possible influence of apoptosis
  35. Research Article
  36. Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
  37. Mini-review
  38. Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
  39. Research Article
  40. GSTP1 A>G polymorphism and chemosensitivity of osteosarcoma: A meta-analysis
  41. Research Article
  42. A meta-analysis of adiponectin gene rs22411766 T>G polymorphism and ischemic stroke susceptibility
  43. Research Article
  44. The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
  45. Research Article
  46. SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
  47. Research Article
  48. Sevoflurane affects evoked electromyography monitoring in cerebral palsy
  49. Case Report
  50. A case report of hereditary spherocytosis with concomitant chronic myelocytic leukemia
  51. Case Report
  52. A case of giant saphenous vein graft aneurysm followed serially after coronary artery bypass surgery
  53. Research Article
  54. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
  55. Review Article
  56. Meningioma recurrence
  57. Case Report
  58. Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature
  59. Case Report
  60. A confusing case report of pulmonary langerhans cell histiocytosis and literature review
  61. Research Article
  62. Effect of hesperetin on chaperone activity in selenite-induced cataract
  63. Research Article
  64. Clinical value of self-assessment risk of osteoporosis in Chinese
  65. Research Article
  66. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
  67. Research Article
  68. Is acute appendicitis still misdiagnosed?
  69. Retraction
  70. Retraction of: application of food-specific IgG antibody detection in allergy dermatosis
  71. Review Article
  72. Platelet Rich Plasma: a short overview of certain bioactive components
  73. Research Article
  74. Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis
  75. Review Article
  76. Standards of anesthesiology practice during neuroradiological interventions
  77. Research Article
  78. Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
  79. Letter to the Editor
  80. ARDS diagnosed by SpO2/FiO2 ratio compared with PaO2/FiO2 ratio: the role as a diagnostic tool for early enrolment into clinical trials
  81. Research Article
  82. Impact of sensory integration training on balance among stroke patients: sensory integration training on balance among stroke patients
  83. Review Article
  84. MicroRNAs as regulatory elements in psoriasis
  85. Review Article
  86. Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
  87. Review Article
  88. Garengeot’s hernia: two case reports with CT diagnosis and literature review
  89. Research Article
  90. Concept of experimental preparation for treating dentin hypersensitivity
  91. Research Article
  92. Hydrogen water reduces NSE, IL-6, and TNF-α levels in hypoxic-ischemic encephalopathy
  93. Research Article
  94. Xanthogranuloma of the sellar region diagnosed by frozen section
  95. Case Report
  96. Laparoscopic antegrade cholecystectomy: a standard procedure?
  97. Case Report
  98. Maxillary fibrous dysplasia associated with McCune-Albright syndrome. A case study
  99. Regular Article
  100. Sialoendoscopy, sialography, and ultrasound: a comparison of diagnostic methods
  101. Research Article
  102. Antibody Response to Live Attenuated Vaccines in Adults in Japan
  103. Conference article
  104. Excellence and safety in surgery require excellent and safe tutoring
  105. Conference article
  106. Suggestions on how to make suboptimal kidney transplantation an ethically viable option
  107. Regular Article
  108. Ectopic pregnancy treatment by combination therapy
  109. Conference article
  110. Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomy
  111. Regular Article
  112. Cusum analysis for learning curve of videothoracoscopic lobectomy
  113. Regular Article
  114. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
  115. Conference article
  116. Plastination: ethical and medico-legal considerations
  117. Regular Article
  118. Investigation and control of a suspected nosocomial outbreak of pan-drug resistant Acinetobacter baumannii in an intensive care unit
  119. Regular Article
  120. Multifactorial analysis of fatigue scale among nurses in Poland
  121. Regular Article
  122. Smoking cessation for free: outcomes of a study of three Romanian clinics
  123. Regular Article
  124. Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis
  125. Special Issue on Italian Society for the Study of Vascular Anomalies
  126. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature
  127. Special Issue on Italian Society for the Study of Vascular Anomalies
  128. Surgical treatment of recidivist lymphedema
  129. Special Issue on Italian Society for the Study of Vascular Anomalies
  130. CT and MR imaging of the thoracic aorta
  131. Special Issue on Italian Society for the Study of Vascular Anomalies
  132. Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma
  133. Special Issue on Italian Society for the Study of Vascular Anomalies
  134. Sternal reconstruction by extracellular matrix: a rare case of phaces syndrome
  135. Special Issue on Italian Society for the Study of Vascular Anomalies
  136. Prenatal diagnosis, 3-D virtual rendering and lung sparing surgery by ligasure device in a baby with “CCAM and intralobar pulmonary sequestration”
  137. Special Issue on Italian Society for the Study of Vascular Anomalies
  138. Serum levels of inhibin B in adolescents after varicocelelectomy: A long term follow up
  139. Special Issue on Italian Society for the Study of Vascular Anomalies
  140. Our experience in the treatment of Malignant Fibrous Hystiocytoma of the larynx: clinical diagnosis, therapeutic approach and review of literature
  141. Special Issue on Italian Society for the Study of Vascular Anomalies
  142. Delayed recurrent nerve paralysis following post-traumatic aortic pseudoaneurysm
  143. Special Issue on Italian Society for the Study of Vascular Anomalies
  144. Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature
  145. Special Issue on Italian Society for the Study of Vascular Anomalies
  146. Celiac axis compression syndrome: laparoscopic approach in a strange case of chronic abdominal pain in 71 years old man
  147. Special Issue on Italian Society for the Study of Vascular Anomalies
  148. A rare case of persistent hypoglossal artery associated with contralateral proximal subclavian stenosis
  149. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  150. Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
  151. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  152. Professional dental and oral surgery liability in Italy: a comparative analysis of the insurance products offered to health workers
  153. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  154. Informed consent in robotic surgery: quality of information and patient perception
  155. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  156. Malfunctions of robotic system in surgery: role and responsibility of surgeon in legal point of view
  157. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  158. Medicolegal implications of surgical errors and complications in neck surgery: A review based on the Italian current legislation
  159. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  160. Iatrogenic splenic injury: review of the literature and medico-legal issues
  161. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  162. Donation of the body for scientific purposes in Italy: ethical and medico-legal considerations
  163. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  164. Cosmetic surgery: medicolegal considerations
  165. Focus on Medico-Legal and Ethical Topics in Surgery in Italy
  166. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues
  167. Review Article
  168. Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia
  169. Review Article
  170. Endoscopic diagnosis and treatment of neuroendocrine tumors of the digestive system
  171. Review Article
  172. Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia
  173. Research Article
  174. Relationship between gastroesophageal reflux disease and Ph nose and salivary: proposal of a simple method outpatient in patients adults
  175. Case Report
  176. Idiopathic pleural panniculitis with recurrent pleural effusion not associated with Weber-Christian disease
  177. Research Article
  178. Morbid Obesity: treatment with Bioenterics Intragastric Balloon (BIB), psychological and nursing care: our experience
  179. Research Article
  180. Learning curve for endorectal ultrasound in young and elderly: lights and shades
  181. Case Report
  182. Uncommon primary hydatid cyst occupying the adrenal gland space, treated with laparoscopic surgical approach in an old patient
  183. Research Article
  184. Distraction techniques for face and smile aesthetic preventing ageing decay
  185. Research Article
  186. Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC
  187. Review Article
  188. Descending necrotizing mediastinitis in the elderly patients
  189. Research Article
  190. Prophylactic GSV surgery in elderly candidates for hip or knee arthroplasty
  191. Research Article
  192. Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer
  193. Research Article
  194. The learning curve of laparoscopic holecystectomy in general surgery resident training: old age of the patient may be a risk factor?
  195. Research Article
  196. Self-gripping mesh versus fibrin glue fixation in laparoscopic inguinal hernia repair: a randomized prospective clinical trial in young and elderly patients
  197. Research Article
  198. Anal sphincter dysfunction in multiple sclerosis: an observation manometric study
Heruntergeladen am 18.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2016-0052/html?lang=de
Button zum nach oben scrollen